JP Morgan Chase’s Clovis Oncology, Inc. CLVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-1,000,000
Closed -$7.02M 6741
2021
Q1
$7.02M Hold
1,000,000
﹤0.01% 2679
2020
Q4
$4.8M Sell
1,000,000
-197,500
-16% -$999K ﹤0.01% 2847
2020
Q3
$7.11M Buy
1,197,500
+1,013,700
+552% +$6.06M ﹤0.01% 2296
2020
Q2
$1.24M Sell
183,800
-230,200
-56% -$1.74M ﹤0.01% 3391
2020
Q1
$2.63M Buy
414,000
+180,700
+77% +$1.45M ﹤0.01% 2760
2019
Q4
$2.43M Buy
233,300
+213,900
+1,103% +$1.56M ﹤0.01% 3238
2019
Q3
$76K Buy
+19,400
New +$157K ﹤0.01% 4997
2019
Q1
Sell
-310,000
Closed -$5.57M 6131
2018
Q4
$5.57M Buy
+310,000
New +$6.33M ﹤0.01% 2489
2018
Q3
Sell
-100,000
Closed -$4.55M 5899
2018
Q2
$4.55M Buy
100,000
+41,500
+71% +$2.02M ﹤0.01% 2763
2018
Q1
$3.09M Buy
+58,500
New +$3.41M ﹤0.01% 2962
2016
Q2
Sell
-520,800
Closed -$10M 5036
2016
Q1
$10M Buy
520,800
+515,800
+10,316% +$10.9M ﹤0.01% 1771
2015
Q4
$175K Hold
5,000
﹤0.01% 3682
2015
Q3
$460K Buy
+5,000
New +$433K ﹤0.01% 3447
2015
Q2
Sell
-1,500
Closed -$111K 4243
2015
Q1
$111K Sell
1,500
-63,500
-98% -$4.48M ﹤0.01% 3901
2014
Q4
$3.64M Buy
+65,000
New +$3.42M ﹤0.01% 2611

Other funds holding CLVS